Technical Analysis for BTI - biOasis Technologies Inc.

Grade Last Price % Change Price Change
A 1.270 4.96% 0.060
BTI closed up 4.96 percent on Monday, September 30, 2024, on 2.1 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
New 52 Week High Strength 0.00%
Stochastic Reached Overbought Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

biOasis Technologies Inc. Description

biOasis Technologies Inc. is a development-stage biopharmaceutical company, which is focused on research, development and commercialization of technologies and products that are intended for the treatment of central nervous system (CNS) diseases and diseases of the brain. The Company researches and develops products for diagnosis and treatment of neurological diseases and disorders. It is engaged in the development of its vectors Transcend and Transcendpep for the transport of therapeutic agents across the blood brain barrier (BBB). The Transcend brain delivery platform exploits the BBB penetrating properties of a recombinant soluble human protein known as melanotransferrin (MTf or p97) and portions thereof. Transcend delivery molecules have the ability to transport a range of molecules across the BBB. The Company owns approximately 30 the United States and foreign patents/applications related to p97 as a BBB delivery vector and as a biomarker for Alzheimer's disease.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Transport Medicine Pharma Pharmaceutical Delivery Disease Biology Biopharmaceutical Diseases Disorders Alzheimer's Disease Neurological Diseases Neurology Biomarker Brain Central Nervous System Nervous System

Is BTI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.27
52 Week Low 0.005
Average Volume 134,607
200-Day Moving Average 0.327
50-Day Moving Average 1.181
20-Day Moving Average 1.190
10-Day Moving Average 1.201
Average True Range 0.024
RSI (14) 74.29
ADX 57.2
+DI 38.300
-DI 5.813
Chandelier Exit (Long, 3 ATRs) 1.197
Chandelier Exit (Short, 3 ATRs) 1.223
Upper Bollinger Bands 1.237
Lower Bollinger Band 1.142
Percent B (%b) 1.35
BandWidth 7.936
MACD Line 0.031
MACD Signal Line 0.033
MACD Histogram -0.0017
Fundamentals Value
Market Cap 86.31 Million
Num Shares 68 Million
EPS -0.06
Price-to-Earnings (P/E) Ratio -22.68
Price-to-Sales 5.40
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.338
Resistance 3 (R3) 1.330 1.300 1.326
Resistance 2 (R2) 1.300 1.283 1.304 1.322
Resistance 1 (R1) 1.285 1.272 1.293 1.293 1.319
Pivot Point 1.255 1.255 1.259 1.259 1.255
Support 1 (S1) 1.240 1.238 1.248 1.248 1.221
Support 2 (S2) 1.210 1.227 1.214 1.218
Support 3 (S3) 1.195 1.210 1.214
Support 4 (S4) 1.203